Business
Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic.
Hi, what are you looking for?
Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic.
Pfizer expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more than doubled to $22 billion.
Pfizer and BioNTech are seeking authorization from US health regulators for use of their vaccine for children aged over six months.
Pfizer and BioNTech have begun a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine.
President Biden announced a doubling of US government purchases of new Pfizer therapeutic pills.
US health authorities on Monday approved Pfizer’s Covid-19 booster shot for children as young as 12.
Pfizer said that clinical trials confirmed its Covid pill drastically reduced hospitalizations and deaths among at-risk people by 90 percent.
The US Food and Drug Administration (FDA) expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds.
Pfizer said Thursday it will sell 10 million Covid-19 treatment courses for Covid-19 to the US government for $5.3 billion, pending approval from regulators. The...
The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine.